Cargando…

Adoptive Transfer of Regulatory T Cells as a Promising Immunotherapy for the Treatment of Multiple Sclerosis

Detalles Bibliográficos
Autores principales:	Duffy, Samuel S., Keating, Brooke A., Moalem-Taylor, Gila
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803619/ https://www.ncbi.nlm.nih.gov/pubmed/31680840 http://dx.doi.org/10.3389/fnins.2019.01107

Ejemplares similares

The Contribution of Immune and Glial Cell Types in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
por: Duffy, Samuel S., et al.
Publicado: (2014)

Immunotherapy targeting cytokines in neuropathic pain
por: Lees, Justin G., et al.
Publicado: (2013)

Effects of Vaccination with Altered Peptide Ligand on Chronic Pain in Experimental Autoimmune Encephalomyelitis, an Animal Model of Multiple Sclerosis
por: Tian, David H., et al.
Publicado: (2013)

Differential Effects of Regulatory T Cells in the Meninges and Spinal Cord of Male and Female Mice with Neuropathic Pain
por: Fiore, Nathan T., et al.
Publicado: (2023)

Peripheral and Central Neuroinflammatory Changes and Pain Behaviors in an Animal Model of Multiple Sclerosis
por: Duffy, Samuel S., et al.
Publicado: (2016)

Editorial: Pain in multiple sclerosis and experimental autoimmune encephalomyelitis
por: Lovett-Racke, Amy, et al.
Publicado: (2022)

Adoptive Cell Transfer: Is it a Promising Immunotherapy for Colorectal Cancer?
por: Fan, Jiaqiao, et al.
Publicado: (2018)

The promise of adoptive cellular immunotherapies in hepatocellular carcinoma
por: Hendrickson, Peter G., et al.
Publicado: (2019)

Epstein–Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis
por: Pender, Michael P, et al.
Publicado: (2014)

Temporal Pattern of ICAM-I Mediated Regulatory T Cell Recruitment to Sites of Inflammation in Adoptive Transfer Model of Multiple Sclerosis
por: Doerck, Sebastian, et al.
Publicado: (2010)

Trial Watch: Adoptive cell transfer immunotherapy
por: Galluzzi, Lorenzo, et al.
Publicado: (2012)

Oxaliplatin-induced haematological toxicity and splenomegaly in mice
por: Lees, Justin G., et al.
Publicado: (2020)

Gap junction proteins and their role in spinal cord injury
por: Tonkin, Ryan S., et al.
Publicado: (2015)

Trial Watch: Adoptive cell transfer for anticancer immunotherapy
por: Aranda, Fernando, et al.
Publicado: (2014)

Trial Watch: Adoptive cell transfer for anticancer immunotherapy
por: Vacchelli, Erika, et al.
Publicado: (2013)

Promising treatments of tomorrow for multiple sclerosis
por: Harrison, Daniel M., et al.
Publicado: (2009)

Active immunization with myelin-derived altered peptide ligand reduces mechanical pain hypersensitivity following peripheral nerve injury
por: Perera, Chamini J, et al.
Publicado: (2015)

Adoptive Transfer of Regulatory Immune Cells in Organ Transplantation
por: Oberholtzer, Nathaniel, et al.
Publicado: (2021)

Technical Considerations for the Generation of Adoptively Transferred T Cells in Cancer Immunotherapy
por: Visioni, Anthony, et al.
Publicado: (2016)

Alteration of Transcriptomic Networks in Adoptive-Transfer Experimental Autoimmune Encephalomyelitis
por: Iacobas, Dumitru A., et al.
Publicado: (2007)

Promising Treatment for Multiple Sclerosis: Mitochondrial Transplantation
por: Picone, Pasquale, et al.
Publicado: (2022)

Metastasectomy Following Immunotherapy with Adoptive Cell Transfer for Patients with Advanced Melanoma
por: Klemen, Nicholas D., et al.
Publicado: (2016)

Neuropathic Pain in Animal Models of Nervous System Autoimmune Diseases
por: Tian, David H., et al.
Publicado: (2013)

Cutaneous Neuroimmune Interactions in Peripheral Neuropathic Pain States
por: Lowy, Daniel B., et al.
Publicado: (2021)

Multiple Sclerosis and the Endogenous Opioid System
por: Dworsky-Fried, Zoë, et al.
Publicado: (2021)

Immunotherapy of Multiple Myeloma: Promise and Challenges
por: Abramson, Hanley N
Publicado: (2021)

Immunotherapy: A Novel Era of Promising Treatments for Multiple Myeloma
por: Castella, Maria, et al.
Publicado: (2018)

Microbial Metabolites in Multiple Sclerosis: Implications for Pathogenesis and Treatment
por: Duarte-Silva, Eduardo, et al.
Publicado: (2022)

A New Hope in Immunotherapy for Malignant Gliomas: Adoptive T Cell Transfer Therapy
por: Chung, Dong-Sup, et al.
Publicado: (2014)

Characterisation of Immune and Neuroinflammatory Changes Associated with Chemotherapy-Induced Peripheral Neuropathy
por: Makker, Preet G. S., et al.
Publicado: (2017)

Experimental immunotherapies for multiple sclerosis
por: Martin, Roland, et al.
Publicado: (1996)

Amyotrophic Lateral Sclerosis: Proteins, Proteostasis, Prions, and Promises
por: McAlary, Luke, et al.
Publicado: (2020)

Overcoming T cell dysfunction in acidic pH to enhance adoptive T cell transfer immunotherapy
por: Navarro, Flor, et al.
Publicado: (2022)

Meta-analysis of the Age-Dependent Efficacy of Multiple Sclerosis Treatments
por: Weideman, Ann Marie, et al.
Publicado: (2017)

Eye Movement Abnormalities in Multiple Sclerosis: Pathogenesis, Modeling, and Treatment
por: Serra, Alessandro, et al.
Publicado: (2018)

Multiple Sclerosis Treatments Affect Monocyte-Derived Microvesicle Production
por: Blonda, Maria, et al.
Publicado: (2017)

Interim guidelines for the assessment and treatment of pain in children with multiple sclerosis
por: Stratton, Catherine, et al.
Publicado: (2023)

Regulatory T Cells As Supporters of Psychoimmune Resilience: Toward Immunotherapy of Major Depressive Disorder
por: Ellul, Pierre, et al.
Publicado: (2018)

3D U-Net for automated detection of multiple sclerosis lesions: utility of transfer learning from other pathologies
por: Wahlig, Stephen G., et al.
Publicado: (2023)

Talquetamab: A promising immunotherapy for multiple myeloma
por: Tariq, Amna, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4tm67vte3on34ftrap4ajfl652